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▼Non-radioactive in situ hybridization has been widely
used as a high-resolution method for detecting specific
mRNAs in tissue sections. However, it has been difficult
to combine two colour reactions to detect the presence of
different transcripts at the single cell level. Our method,
which involves simultaneous hybridization with two differ-
ent riboprobes followed by sequential colour reactions for
each of them, relies on the removal of the first signal before
recording the second one. Thus, this protocol avoids signal
interference and permits the clear identification of single
cells expressing more than one transcript. Moreover, the
ability to use a single optics apparatus to take photographs
of each expression pattern allows the direct analysis of
the relative mRNA levels at the level of single cells in the
section.
We were interested in studying the co-expression of tran-
scripts for different neurotrophic factor receptors (here c-
Ret and Lifrβ) in single motoneurons of the facial motor
nucleus. For a variety of reasons, however, none of the
existing double in situ hybridization (dISH) protocols per-
mits the required resolution of two signals at the single
cell level. Those based on colocalization of a colorimetric
signal with a radioisotopic signal (Ref. 1) do not have a
cellular resolution and, therefore, can only be used to de-
tect common expression ‘domains’. Those using colorimet-
ric and fluorescent signals (Ref. 2, 3, 4, 5, 6) require a dif-
ferent detection system for each signal, making it difficult
to compare expression levels directly. Alternatively, with
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protocols based on colocalization of two colorimetric sig-
nals (Ref. 7), which have the advantage of a fine cellular
localization, a strong signal for one transcript can easily
mask a weaker signal for the other transcript in the same
cell. Here, we describe a simple dISH protocol with which
we are able to avoid these numerous problems and thereby
obtain clear evidence of co-expression in the same cell, even
in cases where expression levels of the two genes are very
different.
In our protocol, a single section is first incubated with
both probes, one labelled with digoxigenin and the other
with fluorescein. The colour reaction for the first probe
is performed using Fast Red (Boehringer Mannheim) and
the result is photographed. The second probe is then re-
vealed using a different colour reaction and the Fast Red
signal is removed using an alcohol dehydration step be-
fore photographing the expression pattern of the second
probe. Alignment of the resulting photographs allows the
comparison of expression levels of the two transcripts on a
cell-by-cell basis
This technique was used to study the pattern of expres-
sion of Lifrβ and c-Ret in the mouse facial nucleus. The
overlapping expression pattern of both genes in newborn
mouse facial motor nucleus is shown in (Fig. 1). Sections
were co-hybridized with two riboprobes that were labelled
with either digoxigenin (Lifrβ) or fluorescein (c-Ret). Lifrβ
was detected first using an alkaline phosphatase-coupled
anti-digoxigenin antibody and the Fast Red substrate, and
the result was photographed (Fig. 1a). After the inactivation
of alkaline phosphatase, the c-Ret probe was detected using
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FIGURE 1. Overlapping expression pattern of Lifrβ and c-Ret in new-born mouse facial motor nucleus. Results from a single section show Lifrβ
transcripts detected first using the Fast Red substrate (a) before recording the c-Ret expression pattern (b). In the adjacent section, the same procedure
was used to detect first the c-Ret transcripts (d) then the Lifrβ transcripts (c). The third section (e, f) was used as a control, where only the Lifrβ probe
was added and the result was detected with Fast Red (e) before processing as if to reveal a second probe (f). The arrow indicates one cell which
co-expresses the two transcripts. The open triangle and arrow head indicate cells which express different levels of the two transcripts.
an alkaline phosphatase-coupled anti-fluorescein antibody
and the Nitro Blue Tetrazolium/Bromo-4 Chloro-3 Indolyl
Phosphate (NBT/BCIP) substrate. Before recording the
expression pattern of the c-Ret probe (Fig. 1b), the Fast Red
signal was removed by a dehydration step. In an adjacent
section, the same procedure was used to detect first the
c-Ret transcripts (Fig. 1d) and then the Lifrβ transcripts (Fig.
1c). Comparison of the two adjacent sections shows that
the order of analysis does not influence the result. Most
motoneurons express both transcripts abundantly (arrows
in Fig. 1a and 1b), but some clearly exhibit a high level of c-
Ret and a very low level of Lifrβ expression (open triangle in
Fig. 1a, 1b and 1c, 1d) or a high level of Lifrβ and a low level
of c-Ret expression (arrow head in Fig. 1a and 1b). In a con-
trol section (Fig. 1e and 1f), only the Lifrβ probe was added
and revealed using Fast Red (Fig. 1e), before processing the
section normally using the second antibody and NBT/BCIP.
No signal was observed after the remaining treatments
(Fig. 1f), indicating that: i) no inappropriate binding of
second antibody occurred; ii) alkaline phosphatase was
completely inactivated; and iii) there was efficient removal
of the Fast Red product. The sequential in situ hybridization
method was also used successfully on whole mount spinal
cords from E14 rats embryos. (Fig. 2) shows the overlap-
ping expression pattern of Islet-1 and c-Ret expressed by
motoneurons seen on a flat mounted spinal cord. Islet-1
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FIGURE 2. Overlapping expression pattern of Islet-1 and c-Ret in whole-mounted and flattened E14 rat embryo spinal cord. Results from a single spinal
cord show Islet-1 transcripts detected first using the Fast Red substrate (a) before recording the c-Ret expression pattern (b). The arrow indicates single
cells which co-express the two transcripts, the open triangle indicates co-expression domains where single cells cannot be identified, and the arrow head
indicates another group of cells that express only the Islet-1 transcripts. FP, floor plate; VH, ventral horn; DH, dorsal horn.
was revealed first with Fast Red (Fig. 2a). The alkaline
phosphatase inactivation step was performed as for sec-
tions. Before recording the expression pattern of c-Ret
revealed with NBT-BCIP (Fig. 2b), the Fast Red signal was
removed by an overnight dehydration step. Although it is
more difficult in such preparations, a few single cells which
co-express the two genes (arrow in Fig. 2) can be identified.
Nevertheless, this sequential in situ hybridization method
allows clear identification of overlapping expression do-
mains (open triangle in Fig. 2a and 2b), avoiding signal
interference whatever the relative expression level of the
two genes.
It remains an interesting possibility that this sequential
staining technique might be adapted to carry out in
situ hybridization with more than two probes. Clearly,
such a protocol will depend on the availability of other
probeantibody combinations and the level of signal
reduction caused by the extra steps.
Protocol
Preparation of probe
An 800-nucleotidemouse Lifrβ clone, representing themid-
dle third of the extracellular domain (nt 820−1620 in
Genbank D26177) in pBluescript II, and a 1.5 Kb frag-
ment of rat Islet-1 provided by T. Jessell (Columbia Uni-
versity, NY, USA) were used to prepare transcripts labelled
with digoxigenin-UTP (DIG-UTP). A c-Ret clone pmcret7
(Ref. 8) (including nt 1444-2864 in Genbank X67812)
in pBluescript II was used to prepare transcripts labelled
with fluorescein-UTP (Fluo-UTP). The Digoxigenin RNA
Labelling (Boehringer Mannheim) and Fluorescein RNA
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Labelling mixes (Boehringer Mannheim) were used accord-
ing to the manufacturer’s protocols.
Section preparation
Sections were prepared, hybridized and washed using a
modification of a protocol described previously (Ref. 9, 10).
Fix embryos in fix buffer (0.1 M sodium phosphate pH
7.4, 0.12 mM CaCl2,4% (w/v) sucrose) with 4% (w/v)
paraformaldehyde (PFA) at 4◦C overnight. Mice older
than P0 can be perfused with the same buffer before
fixing overnight.
Rinse fixed embryos at room temperature 3 × 30 minutes
in fix buffer without PFA.
Transfer embryos to at least 10 × volume of 0.12 M phos-
phate buffer pH 7.2 with 15% sucrose and leave at 4◦C
until they sink: at least 24 h.
Incubate 30 minutes at 37◦C in sodium phosphate pH
7.2 with 15% sucrose and 7.5% gelatin (Merck,
Ref. 104080) dissolved at 50◦C.
The gelatin-impregnated embryo is embedded in the same
phosphate/gelatin buffer solution and quick-frozen for
1 minute in isopentane, chilled to −70◦C in liquid ni-
trogen. Embryos are stored at −80◦C until needed.
Cryostat sections (typically 16 µm) are transferred to
Superfrost Plus slides (Shandon) and air dried for at
least 30 minutes before use, or stored at −20◦C until
required.
Hybridization and subsequent washing
Dilute probe at 0.5 µg/ml in hybridization buffer (0.19 M
NaCl, 10 mM Tris pH 7.2, 5 mM sodium phosphate pH
6.8, 5 mM EDTA pH 8.0, 50% formamide, 10% dextran
sulfate, 1 mg/ml yeast rRNA, 1 × Denhardt’s).
Add 120 µl of probe mix to each slide.
Cover slide with a coverslip.
Hybridize overnight at 70◦C in a sealed box, kept humid
with 1 × SSC, 50% formamide.
Transfer slides into a slide rack containing wash buffer (1 ×
SSC, 50% Formamide, 0.1% Tween-20) prewarmed to
65◦C. First wash for 15 minutes to allow coverslips to
slip off.
Two further washes at 65◦C for 30 minutes each.
Fast Red staining of the first probe
Wash for 2 × 30 minutes at room temperature in 1 ×
MABT (100 mM maleic acid pH 7.5, 150 mM NaCl,
0.1% Tween-20).
Preblocking is carried out for at least 1 h at room tem-
perature in blocking solution MABT with 2% Block-
ing Reagent (Boehringer Mannheim) and 20% heat-
inactivated sheep serum.
Incubation with either sheep anti-digoxigenin-AP Fab frag-
ments (Boehringer Mannheim) or anti-fluorescein-AP
Fab fragments (Boehringer Mannheim), diluted 1/5000
in blocking solution, is carried out in a humidified
chamber at room temperature overnight.
Sections are washed 4 × 10 minutes at room temperature in
MABT and then 2 ×10 minutes in 0.1 M Tris-HCl pH
8.2.
Staining with Fast Red (Boehringer Mannheim) is per-
formed according to manufacturer’s instructions, ex-
cept that we dissolve the Fast Red tablet in an improved
reaction buffer that results in a 4-fold higher signal (0.4
M NaCl, 0.1 M Tris-HCl pH 8.2) (Ref. 11). The stain-
ing reaction is allowed to proceed in a humid chamber
overnight at room temperature.
Stop the reaction by washing the slides in 0.1 M Tris-HCl
pH 8.2 for 10 minutes.
Slides are mounted temporarily in 0.1 M Tris-HCl pH 8.2,
90% glycerol.
The resulting expression pattern is then photographed.
Inactivation of the alkaline phosphatase
Remove the coverslips and the glycerol by washing in 0.1
M Tris-HCl pH 8.2 for 15 minutes.
Inactivate the alkaline phosphatase of the first antibody as
described (Ref. 6) by incubating in 100 mM glycine pH
2.2, 0.1% Tween-20 for 30 minutes.
Wash 2 × 10 minutes in PBS, 0.1% Tween-20 (PBT).
Re-fix with 4% PFA in 1 × PBS for 10 minutes.
Wash a further 4 × 5 minutes with PBT.
NBT/BCIP second probe staining and Fast Red removal
Equilibrate for 2 × 10 minutes with MABT.
Blocking, binding and washing of the second antibody is
done as above (steps 2−4 of Fast Red staining protocol).
Equilibrate 2 × 10 minutes in NBT/BCIP staining buffer
(100 mM NaCl, 50 mM MgCl2, 100 mM Tris pH 9.5,
0.1% Tween-20, and 5 mM levamisole (Sigma), added
just before use).
The staining reaction is started by adding NBT and BCIP
(Boehringer Mannheim) in the staining buffer accord-
ing to manufacturer’s instructions, and allowed to pro-
ceed in a humid chamber overnight at room temper-
ature and/or at 4◦C for longer if necessary (often for
three days).
The reaction is then stopped by washing in water.
Dehydrate sections to remove the Fast Red precipitates by
incubating slides in progressively higher concentra-
tions of ethanol, finishing in 100% for 2 × 10 minutes.
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Finally, the slides are washed twice in Xylene and mounted
with Eukitt (O. Kindler GMBH & Co.) for photograph-
ing.
Whole-mount in situ hybridisation
The whole-mount in situ hybridization is performed as de-
scribed (Ref. 12). Fast Red staining and inactivation of the
alkaline phosphatase is done as described above, except that
the Fast Red signal is removed by an overnight dehydra-
tion step in 100% ethanol. Detailed step-by-step protocols
for probe production, section preparation, as well as whole
mount and tissue section in situ hybridization are available
on request.
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Products Used
Fast Red dye: Fast Red dye from Boehringer
Mannheim
Anti-digoxigenin antibody: Anti-digoxigenin
antibody from Boehringer Mannheim
Fluorescein RNA labelling mix: Fluorescein
RNA labelling mix from Boehringer Mannheim
Blocking reagent: Blocking reagent from
Boehringer Mannheim
Fast Red dye: Fast Red dye from Boehringer
Mannheim
levamisole: levamisole from Sigma
5-bromo-4-chloro-3- indolylphosphate: 5-
bromo-4-chloro-3- indolylphosphate from Boehringer
Mannheim
BCIP: BCIP from Boehringer Mannheim
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